Pregnancy-Associated Exosomes and Their Modulation of T Cell Signaling1
暂无分享,去创建一个
Sibel Akyol | Douglas D. Taylor | C. Gerçel-Taylor | S. Akyol | Cicek Gercel-Taylor | Ç. Gerçel-Taylor | D. Taylor
[1] M. Martínez-Lorenzo,et al. Differential Secretion of Fas Ligand- or APO2 Ligand/TNF-Related Apoptosis-Inducing Ligand-Carrying Microvesicles During Activation-Induced Death of Human T Cells1 , 2001, The Journal of Immunology.
[2] J. Sixma,et al. Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules , 1999 .
[3] D. Taylor,et al. Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects , 2005, British Journal of Cancer.
[4] Simon C Watkins,et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. , 2004, Blood.
[5] T. Mosmann,et al. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? , 1993, Immunology today.
[6] T. Griffith,et al. The role of FasL-induced apoptosis in immune privilege. , 1997, Immunology today.
[7] H. Hsu,et al. Impaired apoptosis and immune senescence – cause or effect? , 2005, Immunological reviews.
[8] P. Allen,et al. Partially Phosphorylated T Cell Receptor ζ Molecules Can Inhibit T Cell Activation , 1999, The Journal of experimental medicine.
[9] L. Zitvogel,et al. Exosome-based immunotherapy , 2004, Cancer Immunology, Immunotherapy.
[10] A. G. Betz,et al. Regulatory T cells mediate maternal tolerance to the fetus , 2004, Nature Immunology.
[11] R. Schwartz. T cell anergy. , 2003, Annual review of immunology.
[12] M. Drayson,et al. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T‐cell subset , 2004, Immunology.
[13] S. Moore,et al. An investigation into the association among preterm birth, cytokine gene polymorphisms and periodontal disease , 2004, BJOG : an international journal of obstetrics and gynaecology.
[14] L. Mincheva-Nilsson,et al. Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level. , 2005, Molecular human reproduction.
[15] D. Darmochwal-Kolarz,et al. T helper 1- and T helper 2-type cytokine imbalance in pregnant women with pre-eclampsia. , 1999, European journal of obstetrics, gynecology, and reproductive biology.
[16] T. Whiteside,et al. Tumor-induced death of immune cells: its mechanisms and consequences. , 2002, Seminars in cancer biology.
[17] Laurence Zitvogel,et al. Molecular Characterization of Dendritic Cell-Derived Exosomes , 1999, The Journal of cell biology.
[18] J. Beck,et al. Maternal periodontitis and prematurity. Part I: Obstetric outcome of prematurity and growth restriction. , 2001, Annals of periodontology.
[19] J. Challis. Understanding pre-term birth. , 2001, Clinical and investigative medicine. Medecine clinique et experimentale.
[20] S. Canevari,et al. Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro , 1999, Clinical & Experimental Metastasis.
[21] J. Hill,et al. Immunodystrophism: evidence for a novel alloimmune hypothesis for recurrent pregnancy loss involving Th1-type immunity to trophoblast. , 2000, Seminars in Reproductive Medicine.
[22] Laurence Zitvogel,et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming , 2001, Nature Medicine.
[23] William McGuire,et al. Epidemiology of preterm birth , 2004, BMJ : British Medical Journal.
[24] C. Melief,et al. B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.
[25] G. Hill. Preterm birth: associations with genital and possibly oral microflora. , 1998, Annals of periodontology.
[26] L. Zitvogel,et al. Tumor-derived exosomes: a new source of tumor rejection antigens. , 2002, Vaccine.
[27] M. Hallman,et al. Peripheral blood lymphocyte subpopulations in schoolchildren born very preterm , 1999, Archives of disease in childhood. Fetal and neonatal edition.
[28] A. Grinberg,et al. Role of the Multiple T Cell Receptor (TCR)-ζ Chain Signaling Motifs in Selection of the T Cell Repertoire , 1997, The Journal of experimental medicine.
[29] M. Martínez-Lorenzo,et al. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. , 1999, Journal of immunology.
[30] P. Burns,et al. Increased accumulation of p53 protein in cisplatin‐resistant ovarian cell lines , 1993, International journal of cancer.
[31] G. Moreu,et al. Relationship between maternal periodontal disease and low-birth-weight pre-term infants. , 2005, Journal of clinical periodontology.
[32] K. Boggess. Pathophysiology of preterm birth: emerging concepts of maternal infection. , 2005, Clinics in perinatology.
[33] F. Dhabhar,et al. Stress-induced enhancement of leukocyte trafficking into sites of surgery or immune activation. , 2005 .
[34] S. Sánchez-Ramón,et al. Pregnancy-induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activity. , 2005, Immunology letters.
[35] K. Haram,et al. Preterm delivery: an overview , 2003, Acta obstetricia et gynecologica Scandinavica.
[36] Douglas D. Taylor,et al. Modulation of T-cell CD3-zeta chain expression during normal pregnancy. , 2002, Journal of reproductive immunology.
[37] M. Varner,et al. Current understanding of genetic factors in preterm birth , 2005, BJOG : an international journal of obstetrics and gynaecology.
[38] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[39] R. Hodes,et al. Fetal Expression of Fas Ligand Is Necessary and Sufficient for Induction of CD8 T Cell Tolerance to the Fetal Antigen H-Y during Pregnancy , 2005, The Journal of Immunology.
[40] S. Moore,et al. A prospective study to investigate the relationship between periodontal disease and adverse pregnancy outcome , 2004, British Dental Journal.
[41] G. Berkowitz,et al. Epidemiology of preterm birth. , 1993, Epidemiologic reviews.
[42] T. Whiteside,et al. Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes. , 1998, The Journal of clinical investigation.
[43] M. C. Terek,et al. The changes of circulating lymphocyte sub‐populations in women with preterm labour: a case‐controlled study , 2002, The Australian & New Zealand journal of obstetrics & gynaecology.
[44] M. Karlsson,et al. "Tolerosomes" are produced by intestinal epithelial cells , 2001, European journal of immunology.
[45] Douglas D. Taylor,et al. Shed membrane fragment modulation of CD3-zeta during pregnancy: link with induction of apoptosis. , 2002, Journal of reproductive immunology.
[46] G. Raposo,et al. Accumulation of Major Histocompatibility Complex Class Ii Molecules in Mast Cell Secretory Granules and Their Release upon Degranulation Generation of Bmmcs Preparation of B Cells Reagents and Monoclonal Antibodies (mabs) Immunofluorescence Staining and Confocal Microscopy Pulse-chase# Labeling and , 2022 .
[47] G. Mor,et al. First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. , 2004, Molecular human reproduction.
[48] D. Green,et al. Activation‐induced cell death in T cells , 2003, Immunological reviews.